Skip to content
MedCompare

Dihydroergotamine

Save $4,481/mo
1718× cheaper

Dihydroergotamine Mesylate Injection is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

United States
$4,484
per month
India
$3
per month
You save
$4,481
99.94% cheaper in India
19.1K US scripts/yr$85.7M potential annual savings$85.8M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC33H37N5O5

SMILES: C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C

Compare the price
US price$4,484per month
India price$3per month
You save$4,48199.94% less

Based on 30 units per month. US $149.46 vs India $0.09 per unit.

Total over 1 periodSave $4,481$4,484 → $3
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$26,886
Estimated travel cost
− $2,300
Net savings after travel
$24,586

Even after travel, you could come out ahead by about $24,586.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Dihydroergotamine is filled about 19.1K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$85.8M
If sourced from India
$49.9K
Potential annual savings
$85.7M
−100%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.